Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BX vs MRNA✓SelectedUSD · MRNABX vs MRNA performance historyLatest closeAs of-4.47%11/20
Stock and ETF performance explorer

BX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.5%
MRNA return
-27.3%
Excess return
+18.8%
Maximum drawdown
-49.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.5%-2.2%-2.3%-4.3%
7D-7.8%-12.7%+4.9%-6.8%
30D+2.1%-20.7%+22.8%+3.7%
3M-20.9%+46.3%-67.1%-24.0%
6M-3.3%+305.2%-308.5%-23.5%
YTD-25.2%+561.2%-586.4%-46.9%
1Y-16.7%+772.1%-788.7%-44.3%
3Y+14.6%+147.0%-132.4%-9.6%
All-8.5%-27.3%+18.8%-20.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling